Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.

  • Authors:
    • T C Hsieh
    • P Burfeind
    • K Laud
    • J M Backer
    • F Traganos
    • Z Darzynkiewicz
    • J M Wu
  • View Affiliations

  • Published online on: August 1, 1999     https://doi.org/10.3892/ijo.15.2.245
  • Pages: 245-297
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Trans-resveratrol, a polyphenol present in red wines and various human foods, is an antioxidant also with reported chemopreventive properties. However, whether resveratrol may exert different effects in malignant cells with a common anatomical origin yet displaying different invasive characteristics is not known. Since invasiveness and metastasis are considered to be the most insidious and life-threatening aspects for all cancers, we compared the ability of resveratrol to control growth and cell cycle transition in the highly invasive MDA-MB-435 with the minimally invasive MCF-7 breast carcinoma cells. The data revealed that resveratrol exerted a greater inhibitory effect on the MDA-MB-435 cells. A diminution of percentage of cells in G1 phase and a corresponding accumulation of cells in S phase of the cell cycle was observed. We also studied the effect of resveratrol on a panel of MDA-MB-435 cells transfected with nm23-H1 and nm23-H2 genes, which have been suggested to play a role in controlling metastasis in breast cancer cells. These cells are designated as Vbeta, 1beta, 1Tbeta, 2beta, and 2Tbeta, respectively. The control Vbeta consists of MDA-MB-435 cells transfected with bacterial beta-glucuronidase. Cells labeled 1beta and 1Tbeta correspond to those carrying beta-glucuronidase and overexpressed wild-type (His118) or mutant (Tyr118, catalytically inactive) nm23-H1 genes. The 2beta and 2Tbeta refer to cells transfected with wild-type and mutant nm23-H2 genes. The responses of these cells to resveratrol were assessed by measuring proliferation, cell cycle phase distribution, and changes in expression of several genes. These studies have shown that resveratrol (25 microM, 3 days) reduced growth of all cell types by 60-80%. Overexpression of both wild-type and catalytically inactive nm23-H1 (1beta, 1Tbeta) but not nm23-H2 (2beta, 2Tbeta) reduced the proportion of cells in G1 phase, compared to the Vbeta control cells. Little changes in expression of PCNA, Rb, p53, and bcl-2 were observed in the five cell types treated with resveratrol, compared to untreated cells. Noted exceptions included reduced expression of Rb protein and increased expression of p53 in 2beta and 2Tbeta cells, and increased expression of bcl-2 in 2beta cells, treated with resveratrol. In contrast, resveratrol upregulated expression of cathepsin D by 50-100% in all cell lines except 1beta. These results suggest that the intrinsic metastatic potential of cancer cells may affect their responses to chemopreventive agents such as resveratrol.

Related Articles

Journal Cover

August 1999
Volume 15 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Hsieh, T., Burfeind, P., Laud, K., Backer, J., Traganos, F., Darzynkiewicz, Z., & Wu, J. (1999). Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.. International Journal of Oncology, 15, 245-297. https://doi.org/10.3892/ijo.15.2.245
MLA
Hsieh, T., Burfeind, P., Laud, K., Backer, J., Traganos, F., Darzynkiewicz, Z., Wu, J."Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.". International Journal of Oncology 15.2 (1999): 245-297.
Chicago
Hsieh, T., Burfeind, P., Laud, K., Backer, J., Traganos, F., Darzynkiewicz, Z., Wu, J."Cell cycle effects and control of gene expression by resveratrol in human breast carcinoma cell lines with different metastatic potentials.". International Journal of Oncology 15, no. 2 (1999): 245-297. https://doi.org/10.3892/ijo.15.2.245